Adverts

Open Access Articles- Top Results for RG7314

RG7314

RG7314
Clinical data
Identifiers
Chemical data

RG7314 is a selective small molecule antagonist of the vasopressin V1A receptor which is under development by Roche for the treatment of autism.[1] As of August 2014, it is in phase II clinical trials for this indication.[2]

See also

References

External links



Lua error in package.lua at line 80: module 'Module:Buffer' not found.